• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸腺蛋白酶体:在产生阳性选择肽方面的可能作用。

Thymoproteasome: probable role in generating positively selecting peptides.

作者信息

Murata Shigeo, Takahama Yousuke, Tanaka Keiji

机构信息

Laboratory of Protein Metabolism, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033, Japan.

出版信息

Curr Opin Immunol. 2008 Apr;20(2):192-6. doi: 10.1016/j.coi.2008.03.002. Epub 2008 Apr 9.

DOI:10.1016/j.coi.2008.03.002
PMID:18403190
Abstract

The proteasome is the protein destroying machinery conserved in all eukaryotes and plays essential roles in various cellular processes. Apart from the conserved 'standard' proteasome, a special type of proteasome called 'immunoproteasome' exists in vertebrates for better presentation of antigenic peptides on MHC class I molecules. Recently, another vertebrate-specific proteasome was discovered in the thymus. This 'thymoproteasome' has a novel catalytic subunit 'beta5t' with unusual enzymatic activity and is expressed exclusively in cortical thymic epithelial cells (cTECs), which catalyze positive selection of developing thymocytes. beta5t-deficient mice exhibit severe impairment in CD8(+) T cell development. These findings suggest that cTECs are quite unique cells capable of presenting a unique set of self-peptides that are not seen in other cells and are required for positive selection of CD8(+) T cells.

摘要

蛋白酶体是所有真核生物中保守的蛋白质破坏机制,在各种细胞过程中发挥着重要作用。除了保守的“标准”蛋白酶体之外,脊椎动物中还存在一种特殊类型的蛋白酶体,称为“免疫蛋白酶体”,用于更好地在MHC I类分子上呈递抗原肽。最近,在胸腺中发现了另一种脊椎动物特有的蛋白酶体。这种“胸腺蛋白酶体”具有一种新型催化亚基“β5t”,具有不寻常的酶活性,并且仅在皮质胸腺上皮细胞(cTEC)中表达,后者催化发育中的胸腺细胞的阳性选择。β5t缺陷小鼠在CD8(+) T细胞发育中表现出严重受损。这些发现表明,cTEC是相当独特的细胞,能够呈递一组在其他细胞中未见的独特自身肽,这些肽是CD8(+) T细胞阳性选择所必需的。

相似文献

1
Thymoproteasome: probable role in generating positively selecting peptides.胸腺蛋白酶体:在产生阳性选择肽方面的可能作用。
Curr Opin Immunol. 2008 Apr;20(2):192-6. doi: 10.1016/j.coi.2008.03.002. Epub 2008 Apr 9.
2
Regulation of CD8+ T cell development by thymus-specific proteasomes.胸腺特异性蛋白酶体对CD8 + T细胞发育的调控。
Science. 2007 Jun 1;316(5829):1349-53. doi: 10.1126/science.1141915.
3
Ontogeny of thymic cortical epithelial cells expressing the thymoproteasome subunit β5t.胸腺皮质上皮细胞表达胸腺蛋白酶体亚基 β5t 的个体发生。
Eur J Immunol. 2011 May;41(5):1278-87. doi: 10.1002/eji.201041375. Epub 2011 Apr 14.
4
β5t-containing thymoproteasome: specific expression in thymic cortical epithelial cells and role in positive selection of CD8+ T cells.β5t 含胸腺蛋白酶体:在胸腺皮质上皮细胞中的特异性表达及其在 CD8+ T 细胞阳性选择中的作用。
Curr Opin Immunol. 2012 Feb;24(1):92-8. doi: 10.1016/j.coi.2012.01.006. Epub 2012 Jan 27.
5
Thymoproteasome shapes immunocompetent repertoire of CD8+ T cells.胸腺蛋白酶体塑造 CD8+ T 细胞的免疫应答库。
Immunity. 2010 Jan 29;32(1):29-40. doi: 10.1016/j.immuni.2009.10.009. Epub 2009 Dec 31.
6
Thymoproteasome subunit-β5T generates peptide-MHC complexes specialized for positive selection.胸腺蛋白酶体亚基-β5T 生成专门用于阳性选择的肽-MHC 复合物。
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6979-84. doi: 10.1073/pnas.1222244110. Epub 2013 Apr 8.
7
Modest cortex and promiscuous medulla for thymic repertoire formation.适度的皮质和混杂的髓质用于胸腺库的形成。
Trends Immunol. 2008 Jun;29(6):251-5. doi: 10.1016/j.it.2008.03.003. Epub 2008 May 9.
8
Immunology. The cutting edge of T cell selection.免疫学。T细胞选择的前沿领域。
Science. 2007 Jun 1;316(5829):1291-2. doi: 10.1126/science.1143806.
9
Thymoproteasome: role in thymic selection and clinical significance as a diagnostic marker for thymic epithelial tumors.胸腺蛋白酶体:在胸腺选择中的作用及其作为胸腺瘤诊断标志物的临床意义。
Arch Immunol Ther Exp (Warsz). 2013 Oct;61(5):357-65. doi: 10.1007/s00005-013-0234-1. Epub 2013 May 7.
10
Thymoproteasome and peptidic self.胸腺蛋白酶体和肽段自身。
Immunogenetics. 2019 Mar;71(3):217-221. doi: 10.1007/s00251-018-1081-3. Epub 2018 Oct 15.

引用本文的文献

1
PI31 is a positive regulator of 20S immunoproteasome assembly.PI31是20S免疫蛋白酶体组装的正向调节因子。
J Cell Sci. 2025 May 15;138(10). doi: 10.1242/jcs.263887. Epub 2025 May 23.
2
PI31 is a positive regulator of 20S immunoproteasome assembly.PI31是20S免疫蛋白酶体组装的正向调节因子。
bioRxiv. 2025 Jan 15:2025.01.15.633194. doi: 10.1101/2025.01.15.633194.
3
The role of proteasomes in tumorigenesis.蛋白酶体在肿瘤发生中的作用。
Genes Dis. 2023 Aug 6;11(4):101070. doi: 10.1016/j.gendis.2023.06.037. eCollection 2024 Jul.
4
Factors determining the sensitivity to proteasome inhibitors of multiple myeloma cells.决定多发性骨髓瘤细胞对蛋白酶体抑制剂敏感性的因素。
Front Pharmacol. 2024 Mar 4;15:1351565. doi: 10.3389/fphar.2024.1351565. eCollection 2024.
5
The thymoproteasome in shaping the CD8 T-cell repertoire.胸腺蛋白酶体在塑造 CD8+ T 细胞库中的作用。
Curr Opin Immunol. 2023 Aug;83:102336. doi: 10.1016/j.coi.2023.102336. Epub 2023 May 19.
6
Tissue-specific proteasomes in generation of MHC class I peptides and CD8 T cells.组织特异性蛋白酶体在 MHC Ⅰ类肽和 CD8 T 细胞生成中的作用。
Curr Opin Immunol. 2022 Aug;77:102217. doi: 10.1016/j.coi.2022.102217. Epub 2022 Jun 8.
7
Microbial proteasomes as drug targets.微生物蛋白酶体作为药物靶点。
PLoS Pathog. 2021 Dec 9;17(12):e1010058. doi: 10.1371/journal.ppat.1010058. eCollection 2021 Dec.
8
At the Cutting Edge against Cancer: A Perspective on Immunoproteasome and Immune Checkpoints Modulation as a Potential Therapeutic Intervention.对抗癌症的前沿领域:关于免疫蛋白酶体和免疫检查点调节作为一种潜在治疗干预措施的观点
Cancers (Basel). 2021 Sep 28;13(19):4852. doi: 10.3390/cancers13194852.
9
Methods for the discovery of small molecules to monitor and perturb the activity of the human proteasome.小分子的发现方法,用于监测和干扰人蛋白酶体的活性。
Future Med Chem. 2021 Jan;13(2):99-116. doi: 10.4155/fmc-2020-0288. Epub 2020 Dec 4.
10
Adaptation of Proteasomes and Lysosomes to Cellular Environments.蛋白酶体和溶酶体对细胞环境的适应。
Cells. 2020 Oct 1;9(10):2221. doi: 10.3390/cells9102221.